PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Psoriasis Therapeutics Market .pdf


Original filename: Psoriasis Therapeutics Market.pdf
Author: Kishor

This PDF 1.5 document has been generated by Microsoft® Word 2010, and has been sent on pdf-archive.com on 03/05/2018 at 13:11, from IP address 116.75.x.x. The current document download page has been viewed 222 times.
File size: 248 KB (7 pages).
Privacy: public file




Download original PDF file









Document preview


Psoriasis Therapeutics Market
Global Industry Analysis, Trends, Market Size and Forecasts up to 2023

A latest report has been added to the wide database of Psoriasis Therapeutics Market by Infinium Global Research. This report studies the
Psoriasis Therapeutics Market by molecule (biologics, small molecules), route of administration (oral, parenteral, topical), dosage forms
(solid, liquid, EMI-solid), mechanism of action (TNF inhibitors, PDE4 inhibitors, il blocker) market status and outlook of global and major
regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in
recent years and to forecast the values for the next six years. Psoriasis Therapeutics Market provides opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major
companies in the Psoriasis Therapeutics Market. According to report the global psoriasis therapeutics market is expected to grow at a CAGR
of 9.7% over the forecast period of 2017 - 2023.
Segments Covered
The report on global psoriasis therapeutics market covers segments such as molecule, route of administration, dosage forms and
mechanism of action. The molecule segments include biologics and small molecules. On the basis of route of administration the global
psoriasis therapeutics market is categorized into oral, parenteral and topical. On the basis of dosage forms the global psoriasis therapeutics
market is categorized into solid, liquid and emi-solid. On the basis of mechanism of action the global psoriasis therapeutics market is
categorized into TNF inhibitors, PDE4 inhibitors, il blocker and others.
Geographic Coverage
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific and Rest of the World. In this section
the key trends and market size for each geography is provided over the period of 2015 – 2023. The countries covered in the Americas region
include the U.S., Canada and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia among others. Moreover, the
countries covered in the European region include Germany, U.K., France, Spain and Rest of Europe. The U.S. drives the growth in the
Americas region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to
rapid growth in economies such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period
of 2017 - 2023.
Companies Profiled:
The report provides profiles of the companies in the global Psoriasis therapeutics market such as, Amgen, Inc., Johnson & Johnson, Eli Lilly
and Company, AstraZeneca, Novartis AG, AbbVie Inc. and Celgene Corporation.

Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides
insights on the factors that are driving and restraining the global psoriasis therapeutics market. Moreover, IGR-Growth Matrix analysis given
in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of psoriasis
therapeutics market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have
highlighted future trends in the psoriasis therapeutics Market that will impact the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis
highlights rise and fall in the market shares of the key players in the market.
This report will help manufacturers, suppliers and distributors of the psoriasis therapeutics market to understand the present and future
trends in this market and formulate their strategies accordingly.
Table of Contents:1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Psoriasis Therapeutics Market Overview
3.1 Introduction
3.2 Market Dynamics

3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.4 IGR – Growth Matrix Analysis
3.5 Competitive Landscape in the global psoriasis therapeutics market
4. Global Psoriasis Therapeutics Market by Molecule 2017 - 2023
4.1 Biologics
4.2 Small Molecules
5. Global Psoriasis Therapeutics Market by Route of Administration 2017 - 2023
5.1 Oral
5.2 Parenteral
5.3 Topical
6. Global Psoriasis Therapeutics Market by Dosage forms 2017 - 2023
6.1 Solid
6.2 Liquid

6.3 Semi-solid
7. Global Psoriasis Therapeutics Market by Mechanism of Action 2017 - 2023
7.1 TNF Inhibitors
7.2 PDE4 Inhibitors
7.3 IL blocker
7.4 Others
8. Global Psoriasis Therapeutics Market by Regions 2017 - 2023
8.1 Americas
8.1.1 Americas Psoriasis Therapeutics Market by Molecule
8.1.2 Americas Psoriasis Therapeutics Market by Route of administration
8.1.3 Americas Psoriasis Therapeutics Market by Dosage forms
8.1.4 Americas Psoriasis Therapeutics Market by Mechanism of Action
8.1.5 Americas Psoriasis therapeutics Market by Country
8.2 Europe
8.2.1 Europe Psoriasis Therapeutics Market by Molecule
8.2.2 Europe Psoriasis Therapeutics Market by Route of administration

8.2.3 Europe Psoriasis Therapeutics Market by Dosage forms
8.2.4 Europe Psoriasis Therapeutics Market by Mechanism of Action
8.2.5 Europe Psoriasis Therapeutics Market by Country
8.3 Asia-Pacific
8.3.1 Asia-Pacific Psoriasis Therapeutics Market by Molecule
8.3.2 Asia-Pacific Psoriasis Therapeutics Market by Route of administration
8.3.3 Asia-Pacific Psoriasis Therapeutics Market by Dosage forms
8.3.4 Asia-Pacific Psoriasis Therapeutics Market by Mechanism of Action
8.3.5 Asia-Pacific Psoriasis Therapeutics Market by Country
8.4 RoW
8.4.1 RoW Psoriasis Therapeutics Market by Molecule
8.4.2 RoW Psoriasis Therapeutics Market by Route of administration
8.4.3 RoW Psoriasis Therapeutics Market by Dosage forms
8.4.4 RoW Psoriasis Therapeutics Market by Mechanism of Action
8.4.5 RoW Psoriasis therapeutics Market by Sub-region

9. Companies Covered
9.1 Amgen, Inc.
9.2 Johnson & Johnson
9.3 Eli Lilly and Company
9.4 AstraZeneca
9.5 Novartis AG
9.6 AbbVie Inc.
9.7 Celgene Corporation
9.8 Other companies in this market
Click the Below View Full Report: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_psoriasis_therapeutics_market


Related documents


psoriasis therapeutics market
over the counter drug market
gastric cancer drugs market
aarkstore blepharitis pipeline review h1 2015
aarkstore endometriosis pipeline review h1 2015
aarkstore oral mucositis pipeline review h1 2015


Related keywords